Home » Newsletters » BioWorld Science

BioWorld Science

April 2, 2014

View Archived Issues

AbbVie disclose novel glucocorticoid receptor modulators

Prana Biotechnology reports preliminary data from phase II IMAGINE trial

First patient enrolled in phase III AN-2728 trial

Novel ultra-fast vaccine formulation shows safety and efficacy in phase IIb trial

Clinigen acquires Savene from SpePharm

Heron Therapeutics initiates label-expansion study of Sustol

Sorrento Therapeutics begins dosing in pivotal bioequivalence study of Cynviloq

Galectin Therapeutics reports biomarker results from first cohort in phase I trial in NASH

Anavex obtains exclusive rights to AF-710B to strengthen Alzheimer's pipeline

NIH funding to progress isradipine into phase III for Parkinson's disease

Jazz Pharmaceuticals and Gentium announce European launch of Defitelio

Clinical safety of abuse-deterrent analgesic formulations

Brazilian group prepares new agents for cancer

Halozyme Therapeutics' CONSISTENT 1 study of Hylenex meets primary endpoint

New MCHR-1 antagonists presented by Bristol-Myers Squibb

Boehringer Ingelheim patents novel sGC activators

FDA grants orphan drug status to Graspa for AML

Janssen submits NDA to the FDA for darunavir/cobicistat fixed-dose combination tablet

LCZ-696 trial in chronic heart failure closes early based on interim results

MicroRNAs may be biomarkers of drug-induced pancreatic injury

Lenvatinib receives orphan drug status from the FDA for two indications

OPKO Health launches 4Kscore test for prostate cancer

Guselkumab is an effective, well-tolerated therapy for psoriasis according to phase II results

Array CGH-SNP analysis may identify undetected cases of myelodysplastic syndromes

GSK ends MAGRIT study of MAGE-A3 cancer immunotherapeutic

FDA advisory committee recommends approval of Afrezza

FDA approves Oralair

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...